Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
SYN

SYN - Synthetic Biologics Inc Stock Price, Fair Value and News

$0.180.00 (0.00%)
Market Closed

Price Targets

SYN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

SYN Price Action

Last 7 days

-10%

Last 30 days

5.9%

Last 90 days

-21.7%

Trailing 12 Months

-87.2%

SYN RSI Chart

SYN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

SYN Valuation

Market Cap

8.3M

Price/Earnings (Trailing)

-0.35

Price/Sales (Trailing)

3.16

EV/EBITDA

0.2

Price/Free Cashflow

-0.49

SYN Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

SYN Fundamentals

SYN Revenue

Revenue (TTM)

2.6M

SYN Earnings

Earnings (TTM)

-23.7M

Earnings Growth (Yr)

55.99%

Earnings Growth (Qtr)

55.12%

SYN Profitability

EBT Margin

-908.15%

Return on Equity

-154.07%

Return on Assets

-61.98%

Free Cashflow Yield

-202.21%

SYN Investor Care

Shares Dilution (1Y)

1112.59%

Diluted EPS (TTM)

-2.35

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20210000
20110000
20100002.6M
Get all data in R, Python etc through our Historical Stock Data APIs

About Synthetic Biologics Inc

SYN
0
 WEBSITEsyntheticbiologics.com

Synthetic Biologics Inc Frequently Asked Questions

SYN is the stock ticker symbol of Synthetic Biologics Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Thu Mar 12 2026, market cap of Synthetic Biologics Inc is 8.26 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Thu Mar 12 2026, SYN's PE ratio (Price to Earnings) is -0.35 and Price to Sales (PS) ratio is 3.16. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SYN PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Synthetic Biologics Inc has provided -0.679 (multiply by 100 for percentage) rate of return.